ALKS Logo

Alkermes plc (ALKS) 

NASDAQ
Market Cap
$5.1B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
530 of 966
Rank in Industry
287 of 554

Largest Insider Buys in Sector

ALKS Stock Price History Chart

ALKS Stock Performance

About Alkermes plc

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia and schizoaffective; and VUMERITY for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting and active secondary progressive diseases. The company is also developing LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and nemvaleukin alfa, an engineered fusion protein to expand tumor-killing immune cells and to avoid the activation of immunosuppressive cells. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Insider Activity of Alkermes plc

Over the last 12 months, insiders at Alkermes plc have bought $0 and sold $3.42M worth of Alkermes plc stock.

On average, over the past 5 years, insiders at Alkermes plc have bought $470,870 and sold $11.23M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 35,000 shares for transaction amount of $815,735 was made by Daglio David Angelo Jr. (director) on 2022‑11‑14.

List of Insider Buy and Sell Transactions, Alkermes plc

2024-12-05SaleEVP R&D, Chief Medical Officer
9,221
0.0058%
$31.50$290,462+0.87%
2024-12-04SaleEVP R&D, Chief Medical Officer
14,349
0.0088%
$30.77$441,550+0.85%
2024-11-27SaleSVP, Chief Commercial Officer
5,208
0.0032%
$29.15$151,813+3.24%
2024-11-11SaleEVP R&D, Chief Medical Officer
58,996
0.0363%
$30.08$1.77M-2.76%
2024-11-06SaleEVP R&D, Chief Medical Officer
10,471
0.0065%
$29.53$309,169-0.15%
2024-03-18SaleSVP, Chief Commercial Officer
10,417
0.0064%
$28.10$292,740-2.80%
2024-02-27SaleVP, Finance (Interim PAO)
2,559
0.0015%
$29.65$75,874-9.16%
2024-02-15Saledirector
2,690
0.0018%
$31.85$85,677-16.34%
2023-06-08Saledirector
2,638
0.0016%
$31.85$84,020-12.09%
2023-06-07Saledirector
2,800
0.0017%
$31.50$88,200-10.69%
2023-05-30SaleSVP, Chief Commercial Officer
27,134
0.0163%
$28.93$784,862-4.59%
2023-05-09Saledirector
41,250
0.0252%
$31.24$1.29M-9.28%
2022-11-14Purchasedirector
35,000
0.0218%
$23.31$815,735+23.30%
2022-06-21SaleSVP, Chief Commercial Officer
7,474
0.0047%
$28.26$211,203-3.00%
2022-05-17SaleSVP, Corp Dev., Alkermes, Inc.
50,000
0.03%
$29.15$1.46M-9.67%
2022-05-10SaleSVP, Corp Dev., Alkermes, Inc.
25,000
0.0154%
$27.22$680,380-0.78%
2022-05-05SaleDirector and CEO, Alkermes plc
93,747
0.0571%
$27.85$2.61M-4.37%
2022-05-03SaleSVP, Corp Dev., Alkermes, Inc.
25,000
0.0151%
$28.62$715,415-8.00%
2022-05-02Sale
10,000
0.0062%
$29.23$292,330-7.62%
2022-04-25Sale
10,000
0.006%
$27.88$278,849-6.29%

Insider Historical Profitability

4.96%
Nichols Christian ToddSVP, Chief Commercial Officer
60703
0.0375%
$31.5404
Hopkinson Craig C.EVP R&D, Chief Medical Officer
59730
0.0369%
$31.5408
LAURENCIN CATO Tdirector
15169
0.0094%
$31.5403
Parisi Samuel JosephVP, Finance (Interim PAO)
7717
0.0048%
$31.5401
ELAN CORP PLC10 percent owner
7750000
4.7898%
$31.5401
POPS RICHARD FDirector and CEO, Alkermes plc
968299
0.5984%
$31.54069
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
232306
0.1436%
$31.54051
BLOOM FLOYD Edirector
127923
0.0791%
$31.54113+9.38%
Cooke Shane
90478
0.0559%
$31.54033
Jackson Blair CurtisEVP, Chief Operating Officer
87915
0.0543%
$31.5402
Daglio David Angelo Jr.director
80000
0.0494%
$31.5410+23.3%
Gaffin David JosephSVP, CLO, Alkermes, Inc.
74597
0.0461%
$31.5407
ANSTICE DAVID Wdirector
73081
0.0452%
$31.5414+44.33%
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS
56889
0.0352%
$31.54016
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
55071
0.034%
$31.54056
Stejbach MarkSVP/Chief Comm Off, Alks Inc
44013
0.0272%
$31.5419+46.24%
Brown Iain MichaelSVP, Chief Financial Officer
42980
0.0266%
$31.5408
DIXON WENDY Ldirector
41300
0.0255%
$31.5412+1.23%
FRATES JAMES MSVP, Alks Inc; CFO ALKS
37234
0.023%
$31.54074
Pugh Gordon GSVP, COO & CRO, Alkermes, Inc.
20587
0.0127%
$31.54036
Wysenski Nancydirector
15829
0.0098%
$31.5431<0.0001%
MCKEON BRIAN Pdirector
10000
0.0062%
$31.5410+4.55%
snyderman nancy lynn MD
9366
0.0058%
$31.5410+14%
BREYER ROBERT Adirector
7156
0.0044%
$31.54047
MITCHELL PAUL Jdirector
7000
0.0043%
$31.54064
Botkin James LSVP, Alkermes Gainesville LLC
2509
0.0016%
$31.5404
Alva Emily Petersondirector
1650
0.001%
$31.5410<0.0001%
HENWOOD GERALDINEdirector
0
0%
$31.5406
Peterson RebeccaSVP, Corporate Communications
0
0%
$31.54030

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$789.59M17.2429.17M-2.84%-$23.12M0.02
The Vanguard Group$545.76M11.9120.16M-3.79%-$21.5M0.01
Wellington Management Company$403.14M8.814.89M-2.29%-$9.45M0.07
State Street$243.74M5.329M-3.73%-$9.45M0.01
T. Rowe Price$225.39M4.928.33M+421.83%+$182.2M0.03
RTW Investments, LP$163.89M3.586.05M+55.18%+$58.28M2.46
Renaissance Technologies$159.37M3.485.89M-2.68%-$4.39M0.25
Pacer Advisors Inc$115.82M2.534.28M+555,557.56%+$115.8M0.29
Geode Capital Management$101.33M2.213.74M+2.88%+$2.83M0.01
Deep Track Capital Lp$94.75M2.073.5M-12.5%-$13.54M0.44
PRIMECAP Management Co$94.02M2.053.47M-2.59%-$2.5M0.07
BNY Mellon$78.03M1.72.88M-12.31%-$10.95M0.02
Hardman Johnston Global Advisors LLC$72.41M1.582.67M-51.16%-$75.84M2.5
Dimensional Fund Advisors$68.03M1.492.51M+4.57%+$2.97M0.02
Charles Schwab$63.26M1.382.34M+8.84%+$5.14M0.01
Artisan Partners$55.93M1.222.07M0%+$00.08
Bank of America$52.98M1.161.96M+40.88%+$15.37M0.01
Morgan Stanley$52.88M1.151.95M-22.44%-$15.3M<0.01
Northern Trust$48.64M1.061.8M-2.54%-$1.27M0.01
First Trust$39.87M0.871.47M-10.79%-$4.82M0.04
Goldman Sachs$37.5M0.821.39M-1.25%-$472,967.040.01
Westfield Capital Management Co Lp$34.72M0.761.28M-21.1%-$9.29M0.18
Jacobs Levy Equity Management$33.9M0.741.25M-0.3%-$101,187.660.12
Nuveen$33.87M0.741.25M-36.33%-$19.33M0.01
American Century Investments$31.88M0.71.18M+12.1%+$3.44M0.02
Segall Bryant & Hamill$29.3M0.641.08M-1.62%-$481,494.100.55
Woodline Partners LP$28.96M0.631.07M-8.61%-$2.73M0.25
Jupiter Fund Management$27.6M0.61.02M-31.4%-$12.63M0.08
Man Group Plc$23.65M0.52873,633-5.67%-$1.42M0.06
Loomis, Sayles & Company$20.77M0.45767,077-0.66%-$138,599.910.03
Panagora$20.65M0.45762,846-2.53%-$536,283.760.1
Two Sigma Advisers LP$18.4M0.4679,700-37.27%-$10.93M0.03
Armistice Capital Llc$18.2M0.4672,218-43.98%-$14.29M0.06
Millennium Management LLC$17.89M0.39660,725+179.53%+$11.49M0.01
Fuller & Thaler Asset Management, Inc.$17.04M0.37629,593+39.52%+$4.83M0.08
HERITAGE ASSET MANAGEMENT INC$16.87M0.37619,211+3.96%+$643,245.340.09
Ameriprise Financial$16.3M0.36601,971-8.2%-$1.45M0.01
Invesco$16.25M0.36600,303-29.38%-$6.76M<0.01
Legal & General$15.79M0.35583,306-4.59%-$759,530.04<0.01
JPMorgan Chase$15.37M0.34567,692-4.47%-$718,925.04<0.01
Squarepoint Ops LLC$15.25M0.33563,519-11.85%-$2.05M0.06
Glenmede$14.05M0.31518,931+7.59%+$991,276.320.07
Palo Alto Investors Lp$13.42M0.29495,592-17.87%-$2.92M1.51
Federated Hermes$13.28M0.29490,472-1.02%-$136,676.430.03
RhumbLine Advisers$13.25M0.29489,591+0.75%+$98,886.500.01
Balyasny Asset Management Llc$13.04M0.29481,656+2,857.85%+$12.6M0.04
AXA$13.02M0.28481,092+64.07%+$5.09M0.04
AllianceBernstein$12.71M0.28469,503+78.73%+$5.6M<0.01
Voloridge Investment Management, LLC$12.54M0.27463,202-29.89%-$5.35M0.05
Teacher Retirement System of Texas$12.21M0.27451,216-0.22%-$27,096.150.08
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.